• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颌骨复发性成釉细胞瘤。一项随访研究。

Recurrent ameloblastoma of the jaws. A follow-up study.

作者信息

Olaitan A A, Arole G, Adekeye E O

机构信息

Department of Dental Surgery, Ahmadu Bello University Teaching Hospital, Kaduna, Nigeria.

出版信息

Int J Oral Maxillofac Surg. 1998 Dec;27(6):456-60. doi: 10.1016/s0901-5027(98)80037-4.

DOI:10.1016/s0901-5027(98)80037-4
PMID:9869287
Abstract

Twenty-six cases of recurrent ameloblastoma of the jaws within a 15-year period are presented. They represent 8.9% of all cases of ameloblastoma seen in this period. The highest incidence was found in the third decade of life. There is a higher incidence of recurrences in the mandible (16/26) as compared to the maxilla (6/26). Over 80% of the recurrences presented within five years of primary surgery, emphasising the need for adequate and intensive follow-up during this critical period. Three patients whose lesions were operated on in the mandible showed similar lesions in the maxilla after a period of time. Conservative procedures at primary surgery produced the most recurrences. The cure rate for surgery of maxillary ameloblastoma was comparatively poor. The need for good visibility, adequate access and radical surgery in maxillary ameloblastoma is stressed.

摘要

本文报告了15年间26例颌骨复发性成釉细胞瘤病例。它们占该时期所见所有成釉细胞瘤病例的8.9%。发病率最高的年龄段为第三个十年。与上颌骨(6/26)相比,下颌骨的复发率更高(16/26)。超过80%的复发发生在初次手术后的五年内,这强调了在这一关键时期进行充分和密集随访的必要性。三名下颌骨病变接受手术的患者在一段时间后上颌骨出现了类似病变。初次手术采用保守术式导致的复发最多。上颌骨成釉细胞瘤的手术治愈率相对较低。强调了上颌骨成釉细胞瘤手术中良好视野、充分显露和根治性手术的必要性。

相似文献

1
Recurrent ameloblastoma of the jaws. A follow-up study.颌骨复发性成釉细胞瘤。一项随访研究。
Int J Oral Maxillofac Surg. 1998 Dec;27(6):456-60. doi: 10.1016/s0901-5027(98)80037-4.
2
Ameloblastoma of the jaws: a critical reappraisal based on a 40-years single institution experience.颌骨造釉细胞瘤:基于 40 年单机构经验的批判性再评价。
Oral Oncol. 2010 Jan;46(1):61-4. doi: 10.1016/j.oraloncology.2009.11.002. Epub 2009 Dec 9.
3
A classification system for recurrent ameloblastoma of the jaws--review of 30 cases in Nigerians.颌骨复发性成釉细胞瘤的分类系统——尼日利亚30例病例回顾
Nig Q J Hosp Med. 2012 Jan-Mar;22(1):44-51.
4
Ameloblastoma: biological profile of 3677 cases.成釉细胞瘤:3677例病例的生物学特征
Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99. doi: 10.1016/0964-1955(94)00037-5.
5
Odontogenic tumours: a 15-year review from Ibadan, Nigeria.牙源性肿瘤:来自尼日利亚伊巴丹的15年回顾
Br J Oral Maxillofac Surg. 1997 Oct;35(5):363-7. doi: 10.1016/s0266-4356(97)90411-3.
6
Ameloblastoma: the Zimbabwean experience over 10 years.成釉细胞瘤:津巴布韦十年经验
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Jul;82(1):38-41. doi: 10.1016/s1079-2104(96)80375-1.
7
Surgical treatment of recurring ameloblastoma, are there options?复发性成釉细胞瘤的外科治疗,有哪些选择?
Br J Oral Maxillofac Surg. 2013 Dec;51(8):762-6. doi: 10.1016/j.bjoms.2013.08.013. Epub 2013 Sep 16.
8
Management of recurrent ameloblastoma of the jaws; a 40-year single institution experience.颌骨复发性成釉细胞瘤的治疗;40 年单机构经验。
Oral Oncol. 2011 Feb;47(2):145-6. doi: 10.1016/j.oraloncology.2010.11.008. Epub 2010 Dec 14.
9
Clinical profile of ameloblastoma among Filipino patients in Metro Manila hospitals.马尼拉大都会医院菲律宾患者成釉细胞瘤的临床特征
J Philipp Dent Assoc. 1997;49(3):5-19.
10
Recurrent ameloblastoma following osseous reconstruction--a review of twenty years.骨重建后复发性成釉细胞瘤——二十年回顾
J Craniomaxillofac Surg. 2009 Jan;37(1):36-41. doi: 10.1016/j.jcms.2008.07.009. Epub 2008 Nov 20.

引用本文的文献

1
Tale of Ameloblastoma - An Experience Spanning Two Decades.成釉细胞瘤的故事——二十年的经历
J Maxillofac Oral Surg. 2025 Apr;24(2):500-507. doi: 10.1007/s12663-024-02197-2. Epub 2024 May 20.
2
Factors related to risk of recurrence and recurrence free survival in ameloblastoma of the Jaws: A single centre retrospective analysis.颌骨成釉细胞瘤复发风险及无复发生存相关因素:单中心回顾性分析
Oral Maxillofac Surg. 2024 Dec 30;29(1):22. doi: 10.1007/s10006-024-01321-3.
3
Hybrid Calcifying Epithelial Odontogenic Tumor and Ameloblastoma: A Report of an Extremely Rare Condition.
混合性钙化上皮性牙源性肿瘤和成釉细胞瘤:1例极其罕见病例报告
Galen Med J. 2023 Dec 17;12:e3144. doi: 10.31661/gmj.v12i.3144. eCollection 2023.
4
NKG2D (Natural Killer Group 2, Member D) ligand expression and ameloblastoma recurrence: a retrospective immunohistological pilot study.NKG2D(自然杀伤细胞组 2,成员 D)配体表达与造釉细胞瘤复发:一项回顾性免疫组织化学的初步研究。
BMC Oral Health. 2024 Sep 17;24(1):1102. doi: 10.1186/s12903-024-04873-8.
5
Segmental resection vs. partial resection on treating solid multicystic ameloblastomas of the jaws - recurrence rates: A systematic review and meta-analysis.节段性切除与部分切除治疗颌骨实性多囊性成釉细胞瘤的复发率:一项系统评价与荟萃分析
J Clin Exp Dent. 2023 Jul 1;15(7):e518-e525. doi: 10.4317/jced.60502. eCollection 2023 Jul.
6
Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate.复发性成釉细胞瘤:临床表现与无病生存率
J Oncol. 2022 Aug 9;2022:2148086. doi: 10.1155/2022/2148086. eCollection 2022.
7
Development and Validation of a Prognostic Nomogram for Postoperative Recurrence-Free Survival of Ameloblastoma.成釉细胞瘤术后无复发生存的预后列线图的开发与验证
Cancer Manag Res. 2021 Jun 1;13:4403-4416. doi: 10.2147/CMAR.S307517. eCollection 2021.
8
Ameloblastoma: clinical presentation, multidisciplinary management and outcome.成釉细胞瘤:临床表现、多学科管理及预后
Case Reports Plast Surg Hand Surg. 2021 Feb 22;8(1):27-36. doi: 10.1080/23320885.2021.1886854.
9
Pure endoscopic transsphenoidal treatment of skull base ameloblastoma with intracranial extension: Case report and literature review.纯内镜经蝶窦治疗伴颅内侵犯的颅底成釉细胞瘤:病例报告及文献复习
Surg Neurol Int. 2020 Aug 1;11:228. doi: 10.25259/SNI_45_2020. eCollection 2020.
10
Recurrent Ameloblastoma Involving Fibula Neo-mandible: Management with Digital Planning and Reconstruction Using a Contralateral Free Fibula Flap.复发性成釉细胞瘤累及腓骨重建下颌骨:应用对侧游离腓骨瓣的数字化规划与重建治疗
Cureus. 2020 Apr 29;12(4):e7880. doi: 10.7759/cureus.7880.